Full Name
Alan Prem Kumar
Variants
Kumar, A.P.
Kumar, A.
Prem Kumar, A.
Kumar, Alan Prem Rem
 
 
 
Email
apkumar@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Department:  DEAN'S OFFICE (MEDICINE)
Department:  SINGAPORE-MIT ALLIANCE

Results 21-26 of 26 (Search time: 0.004 seconds).

Issue DateTitleAuthor(s)
2128-Jul-2012Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancerShanmugam, M.K. ; Nguyen, A.H.; Kumar, A.P. ; Tan, B.K.H.; Sethi, G.
221-Jun-2013Ursolic acid in cancer prevention and treatment: Molecular targets, pharmacokinetics and clinical studiesShanmugam, M.K. ; Dai, X.; Kumar, A.P. ; Tan, B.K.H.; Sethi, G.; Bishayee, A.
23Jul-2011Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude miceShanmugam, M.K. ; Rajendran, P.; Li, F.; Nema, T.; Vali, S.; Abbasi, T.; Kapoor, S.; Sharma, A.; Kumar, A.P. ; Ho, P.C. ; Hui, K.M.; Sethi, G.
2412-Mar-2012Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathwaysShanmugam, M.K. ; Ong, T.H.; Kumar, A.P. ; Lun, C.K.; Ho, P.C. ; Wong, P.T.H.; Hui, K.M.; Sethi, G.
252014γ-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse modelSiveen, K.S.; Ahn, K.S.; Ong, T.H.; Shanmugam, M.K. ; Li, F.; Yap, W.N.; Kumar, A.P. ; Fong, C.W.; Tergaonkar, V.; Hui, K.M. ; Sethi, G.
26May-2011γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: Potential role as an antiproliferative, pro-apoptotic and chemosensitizing agentRajendran, P.; Li, F.; Manu, K.A. ; Shanmugam, M.K. ; Loo, S.Y.; Kumar, A.P. ; Sethi, G.